![Gary Latham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Latham
Directeur Technique/Scientifique/R&D chez
BIO-TECHNE CORPORATION
Profil
Gary Latham is Chief Technology Officer & Vice President at Bio-Techne Corp.
since 2023.
Formerly, Dr. Latham was Chief Scientific Officer at Asuragen, Inc. Education includes a doctorate from Vanderbilt University.
Postes actifs de Gary Latham
| Sociétés | Poste | Début |
|---|---|---|
| BIO-TECHNE CORPORATION | Directeur Technique/Scientifique/R&D | 06/08/2023 |
Anciens postes connus de Gary Latham
| Sociétés | Poste | Fin |
|---|---|---|
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Directeur Technique/Scientifique/R&D | - |
Formation de Gary Latham
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bio-Techne Corp.
 Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
